V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190009884 | 190006251 | 1.73 | 81.7 | Palliative (P) | 2018-09-08 | 2018-09-08 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | N | EURAMOS TRIAL | 101798406 |
| 190009897 | 190006252 | 1.59 | 59.2 | Adjuvant (A) | 2019-08-25 | 2019-10-25 | Trial Unspecified | 02 | N | NOT MATCHED | 101513878 |
| 190009905 | 190006253 | 1.77 | 53.5 | null | 2019-07-23 | 2019-08-06 | EW EuroEwing 2012 Arm B IE | 02 | null | EW EUROEWING 2012 ARM B IE | 100935290 |
| 190009914 | 190006255 | 0 | 4.5 | 03 | 2018-02-27 | 2018-08-28 | EW EuroEwing 2012 Arm B VC | 2 | Y | CAPECITABINE + GEMCITABINE | 101292391 |
| 190009917 | 190006256 | 1.66 | 98 | null | 2021-07-17 | 2021-08-14 | VAI (Ifos 3g/m2) | null | null | MAP | 100316004 |
| 190009931 | 190006257 | 1.73 | 81.85 | Curative (C) | 2020-05-28 | 2020-07-05 | Docetaxel 75mg/m2 (21 day) | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100621537 |
| 190009932 | 190006258 | 1.88 | 53 | Curative (C) | 2019-09-02 | 2019-09-16 | Capecitabine (21days) + Carboplatin | 02 | N | DHAP | 101741327 |
| 190009940 | 190006259 | 1.58 | 65.4 | 03 | 2016-09-06 | 2017-02-21 | EW EuroEwing 2012 Arm A VAI | 01 | N | DOXORUBICIN + METHOTREXATE | 101142333 |
| 190009944 | 190006260 | 1.84 | 25 | Adjuvant (A) | 2016-08-30 | 2016-09-24 | Docetaxel | 02 | N | OST AI | 101284814 |
| 190009950 | 190006261 | 0 | 19.4 | Neo-adjuvant (N) | 2019-11-06 | 2019-11-06 | Methotrexate Intermed dose (1g/m2) | null | Y | METHOTREXATE | 100607227 |
| 190009952 | 190006262 | 1.7 | 111 | Curative (C) | 2016-09-16 | 2016-10-06 | Etoposide + Ifosfamide (3 days) | 02 | N | ETOPOSIDE + IFOSFAMIDE | 100639670 |
| 190009967 | 190006263 | 1.81 | 49.8 | Neo-adjuvant (N) | 2018-06-02 | 2018-06-02 | CARBOPLATIN + ETOPOSIDE | 02 | N | METHOTREXATE HIGH DOSE | 101253879 |
| 190009977 | 190006264 | 0 | 0 | Curative (C) | 2019-12-06 | 2019-12-06 | Doxorubicin + Ifosfamide | 02 | null | DHAP | 101725784 |
| 190009987 | 190006265 | 1.61 | 79.8 | null | 2016-02-01 | 2016-07-05 | Dox + HD Mtx (post PAM) | 02 | N | VIDE | 100962902 |
| 190009996 | 190006267 | 1.63 | 55.8 | Neo-adjuvant (N) | 2020-10-30 | 2021-05-25 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 101230444 |
| 190010002 | 190006268 | 0 | 21.6 | null | 2020-02-29 | 2020-03-01 | Liposomal Doxorubicin (Caelyx) | 1 | null | TRIAL | 100064157 |
| 190010003 | 190006269 | 1.62 | 59.55 | null | 2017-09-23 | 2017-10-05 | EW EuroEwing 2012 Arm A VAC | 02 | null | PACLITAXEL | 101650109 |
| 190010011 | 190006270 | 0 | 74.9 | null | 2020-01-22 | 2020-01-29 | METHOTREXATE | 02 | N | METHOTREXATE | 100983073 |
| 190010014 | 190006271 | 0 | null | null | 2019-10-23 | 2019-11-05 | Docetaxel+Gemcitabine (no prior RT) | 02 | null | DOCETAXEL + GEMCITABINE | 101366220 |
| 190010020 | 190006272 | 1.63 | 84.5 | Neo-adjuvant (N) | 2018-08-12 | 2018-12-27 | Dox + HD Mtx (post PAM) | 02 | N | CYCLOPHOSPHAMIDE | 100707734 |
| 190010035 | 190006273 | 1.73 | 67 | null | 2018-09-15 | 2018-09-15 | EW EuroEwing 2012 Arm B IE | N | N | EW EUROEWING 2012 ARM B IE | 101667228 |
| 190010044 | 190006274 | 1.82 | 24.5 | Curative (C) | 2021-12-18 | 2022-03-19 | DOXORUBICIN | N | N | DOXORUBICIN | 101484428 |
| 190010045 | 190006275 | 1.67 | 67.4 | Curative (C) | 2019-07-31 | 2019-12-14 | STS Rhabdo VIT0910 Vinc Irino Temoz | 02 | N | EURO-EWING | 100182411 |
| 190010050 | 190006276 | 1.9 | 51.3 | Palliative (P) | 2021-01-04 | 2021-07-22 | OST Euramos 1 Closed Trial - A | 02 | N | OST A | 100348450 |
| 190010052 | 190006277 | 0.7 | 42.5 | Palliative (P) | 2018-01-09 | 2018-06-12 | Bevacizumab | 02 | null | OST MIFAMURTIDE | 101557901 |
| 190010063 | 190006278 | 1.71 | 59.3 | Palliative (P) | 2017-05-07 | 2017-05-28 | Docetaxel + Gemcitabine (prior RT) | 02 | N | DOCETAXEL + GEMCITABINE | 101523165 |
| 190010079 | 190006279 | 0 | 26.6 | null | null | 2019-02-08 | Cyclophosphamide + Topotecan | 02 | N | EW EUROEWING 2012 ARM A VAI | 100830105 |
| 190010083 | 190006280 | 1.79 | 50.75 | Neo-adjuvant (N) | 2019-08-01 | 2019-08-05 | Doxorubicin 75mg/m2 | 02 | Y | DOXORUBICIN | 101195942 |
| 190010085 | 190006281 | 0 | 37.4 | null | 2016-09-27 | 2016-10-01 | OST Rel Ifosfamide Etoposide | N | N | DOXORUBICIN + METHOTREXATE | 100022744 |
| 190010086 | 190006282 | 0 | 57.6 | Adjuvant (A) | 2017-12-15 | 2017-12-21 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 100813051 |
| 190010091 | 190006283 | 1.75 | 93.05 | null | 2019-10-01 | 2019-10-01 | null | null | Y | OST IE | 101727589 |
| 190010093 | 190006284 | 0 | 38.9 | null | 2021-03-21 | 2021-08-11 | IMATINIB | null | null | IRINOTECAN + TEMOZOLOMIDE | 101125124 |
| 190010109 | 190006286 | null | 70.4 | Palliative (P) | 2017-11-19 | 2017-11-25 | Imatinib 400mg | 02 | N | EW REL REECUR IRINOTECAN/TEMOZOLOMIDE | 100844569 |
| 190010111 | 190006287 | 1.72 | 20 | Adjuvant (A) | 2016-06-30 | 2016-08-18 | EW Rel rEECur Gemcitabine/Docetaxel | 02 | N | TRIAL | 101241255 |
| 190010113 | 190006288 | 1.89 | 78.3 | Adjuvant (A) | 2022-03-23 | 2022-04-21 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | 02 | N | TRIAL | 100094259 |
| 190010114 | 190006289 | 1.81 | 55.7 | Adjuvant (A) | 2019-11-14 | 2019-12-27 | EW Rel rEECur Topotecan/Cyclophosphamide | 02 | N | CISPLATIN + DOXORUBICIN | 101177950 |
| 190010117 | 190006290 | 0 | 40.9 | Curative (C) | 2019-06-21 | 2019-07-17 | CISPLATIN + GEMCITABINE | 02 | N | NOT MATCHED | 100494715 |
| 190010122 | 190006291 | 1.78 | 77 | Neo-adjuvant (N) | 2018-12-03 | 2019-04-19 | EURAMOS TRIAL | 02 | N | EW REL REECUR TOPOTECAN/CYCLOPHOSPHAMIDE | 100562215 |
| 190010123 | 190006292 | 1.78 | 74 | null | 2017-03-28 | 2017-04-19 | EW EuroEwing 2012 Arm B IE | 02 | null | EW EUROEWING 2012 ARM B IE | 100042074 |
| 190010126 | 190006293 | 1.72 | 62.2 | null | 2020-05-06 | 2020-05-27 | DOXORUBICIN | 02 | null | DOXORUBICIN | 100810176 |
| 190010128 | 190006294 | 1.55 | 91.25 | Palliative (P) | 2019-11-17 | 2019-11-18 | Trabectedin | 02 | N | STS RHABDO RMS 2005 2ND TOPO CYCLO | 101335572 |
| 190010131 | 190006295 | 1.9 | 52 | Adjuvant (A) | 2018-06-23 | 2018-12-01 | Cyclophosphamide + Vincristine | N | N | DOXORUBICIN + METHOTREXATE | 101245049 |
| 190010133 | 190006296 | 1.52 | 41 | Curative (C) | 2018-06-06 | 2019-02-28 | Bendamustine+Rituximab (1st Course) | 02 | null | EW EUROEWING 2012 ARM A/B ZOL ACID | 100458479 |
| 190010137 | 190006297 | 1.65 | 65 | Neo-adjuvant (N) | 2018-05-10 | 2018-05-12 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 100807503 |
| 190010146 | 190006298 | 1.63 | 53 | Palliative (P) | 2018-01-20 | 2018-08-13 | DOCETAXEL + GEMCITABINE | null | null | DOCETAXEL + GEMCITABINE | 100523946 |
| 190010150 | 190006299 | 1.75 | 35 | Palliative (P) | 2018-07-28 | 2018-08-02 | Carboplatin + Doxorubicin | 02 | N | METHOTREXATE HIGH DOSE | 100080628 |
| 190010151 | 190006300 | 1.83 | 16.8 | Palliative (P) | 2019-09-03 | 2019-09-13 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 101185899 |
| 190010169 | 190006301 | 1.57 | 47.5 | Curative (C) | 2017-07-08 | 2017-07-22 | Trial Unspecified | 02 | N | NB RELAPSED CYCLOPHOSPHAMIDE AND TOPOTECAN | 100703440 |
| 190010174 | 190006302 | 1.83 | 74.4 | null | 2019-05-15 | 2019-11-19 | EW EuroEwing 2012 Arm B IE | 02 | null | EW EUROEWING 2012 ARM B IE | 100302019 |
| 190010178 | 190006303 | 1.66 | 57.9 | Palliative (P) | 2019-07-04 | 2019-07-18 | Bevacizumab 7.5mg/kg | 02 | null | TRIAL | 101243503 |